Achim's practice covers a wide range of chemical, pharmaceutical and high tech inventions, and he is acting for a diverse range of companies across these technologies, from start-ups to multinationals.
Achim regularly advises clients on the IP aspects of complex technologies, and on the creation and management of cost-effective IP portfolios.
He also regularly represents clients in Opposition and Appeal Proceedings before the European Patent Office, and often supports clients in multi-jurisdictional contentious situations.
Another field involves due diligence investigations into IP portfolios of technology companies, primarily for venture capital and private equity investors.
Achim is presently serving as President of the LES Benelux.
Achim is qualified as a Dutch, Belgian and European Patent Attorney, and he is a registered European Trade Mark and Design Attorney.
Dr. Rer. Nat.
CEIPI Patent Litigation
"Achim Krebs appreciates what clients really need and gives made-to-measure advice. He is strategic and has a strong commercial understanding of intellectual property and how it can be used to serve business purposes.” He protects chemical, pharmaceutical and mechanical inventions from his base at HGF in The Hague.
October 25th 2022
March 7th 2022
October 12th 2020
November 4th 2019
April 21st 2016
September 6th 2013
March 22nd 2012
President of the Licensing Executive Society for the Benelux for 2020/2021. Secretary LES Benelux 2008-2018.
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …Event details
The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …Read article
Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them. This means that communications are deemed to …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …Event details
Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …Event details
The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.